Abstract
Cancer is one of the major causes of death in human beings. While traditional cancer treatments kill cancerous cells, they negatively affect normal cells. In addition, the side effects and high medical costs of treatment prevent effective management of cancer. Nonetheless, anticancer peptides have gained popularity over the recent years as potential therapeutic agents that may complement traditional therapies. Compared to conventional wet-lab experiments, computation-based methods provide a promising platform for high-throughput identification of peptides that have anticancer activity. Therefore, this review summarizes the currently available databases for anticancer peptides/proteins. This is a survey of 22 recently published in-silico methods that aim to predict anticancer peptides accurately. More specifically, the article details the benchmark datasets, feature construction, feature selection, machine learning algorithms, assessment criteria, comparison of different methods, and publicly available predictors. We also compare the prediction performance of these predictors to the benchmark dataset. Finally, the study makes several recommendations concerning the future development of databases for anticancer peptides and methods that can be used to predict anticancer peptides.
Keywords: Anticancer peptide, In-silico, Machine learning, Feature construction, Feature selection, Cancer.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:Survey of In-silico Prediction of Anticancer Peptides
Volume: 21 Issue: 15
Author(s): Nan Ye*
Affiliation:
- School of Finance and Economics, Xinyang Agriculture and Forestry University, Xinyang 464000,China
Keywords: Anticancer peptide, In-silico, Machine learning, Feature construction, Feature selection, Cancer.
Abstract: Cancer is one of the major causes of death in human beings. While traditional cancer treatments kill cancerous cells, they negatively affect normal cells. In addition, the side effects and high medical costs of treatment prevent effective management of cancer. Nonetheless, anticancer peptides have gained popularity over the recent years as potential therapeutic agents that may complement traditional therapies. Compared to conventional wet-lab experiments, computation-based methods provide a promising platform for high-throughput identification of peptides that have anticancer activity. Therefore, this review summarizes the currently available databases for anticancer peptides/proteins. This is a survey of 22 recently published in-silico methods that aim to predict anticancer peptides accurately. More specifically, the article details the benchmark datasets, feature construction, feature selection, machine learning algorithms, assessment criteria, comparison of different methods, and publicly available predictors. We also compare the prediction performance of these predictors to the benchmark dataset. Finally, the study makes several recommendations concerning the future development of databases for anticancer peptides and methods that can be used to predict anticancer peptides.
Export Options
About this article
Cite this article as:
Ye Nan *, Survey of In-silico Prediction of Anticancer Peptides, Current Topics in Medicinal Chemistry 2021; 21 (15) . https://dx.doi.org/10.2174/1568026621666210612030536
DOI https://dx.doi.org/10.2174/1568026621666210612030536 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacology of the Human Saphenous Vein
Current Vascular Pharmacology EGF Receptor as a Drug Target in Arterial Hypertension
Mini-Reviews in Medicinal Chemistry Towards Optimal Heart Failure Care: Couples-Oriented Strategies to Improve Patient Adherence and Health Outcomes
Current Cardiology Reviews Ventricular and Vascular Stiffening in Aging and Hypertension
Current Hypertension Reviews Chemometric Assisted Simultaneous Analysis of Verapamil Hydrochloride, Gliclazide and Simvastatin in Bulk Drug and Fixed Dose Combinatinos (polypill) - A Futuristic Approach
Current Analytical Chemistry History, Principle and Techniques for Waveform Optimization in External Defibrillations
Recent Patents on Engineering Functional Effects of Levosimendan in Rat Basilar Arteries In Vitro
Current Neurovascular Research Relaxin in Vascular Physiology and Pathophysiology: Possible Implications in Ischemic Brain Disease
Current Neurovascular Research Nitric Oxide is a Central Common Metabolite in Vascular Dysfunction Associated with Diseases of Human Pregnancy
Current Vascular Pharmacology Novel Pharmacologic Approaches to the Management of Sepsis: Targeting the Host Inflammatory Response
Recent Patents on Inflammation & Allergy Drug Discovery Clinical Management of the Cardiovascular Failure in Sepsis
Current Vascular Pharmacology How to Measure Exercise Performance
Current Respiratory Medicine Reviews Relationships of Beta2- and Beta3--Adrenoceptor Polymorphisms with Obesity, Hypertension and Metabolic Syndrome
Current Hypertension Reviews Pathophysiology, Diagnosis and Clinical Management of Hepatorenal Syndrome: From Classic to New Drugs
Current Vascular Pharmacology Targeting Striatal Metabotropic Glutamate Receptor Type 5 in Parkinson’s Disease: Bridging Molecular Studies and Clinical Trials
CNS & Neurological Disorders - Drug Targets Impact of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptors Blockers on Mortality in Acute Heart Failure Patients with Left Ventricular Systolic Dysfunction in the Middle East: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE)
Current Vascular Pharmacology Super-Resolution Based Enhancement of Cardiac MR Images
Current Medical Imaging Release of Adenosine and ATP During Ischemia and Epilepsy
Current Neuropharmacology Treating Asthma as a Neuroelectrical Disorder
Inflammation & Allergy - Drug Targets (Discontinued) Rheumatoid Arthritis: An Autoimmune Disease with Female Preponderance and Cardiovascular Risk Equivalent to Diabetes Mellitus: Role of Cardiovascular Magnetic Resonance
Inflammation & Allergy - Drug Targets (Discontinued)